aTyr Pharma traded at $6.11 this Friday November 13th, decreasing $0.11 or 1.69 percent since the previous trading session. Looking back, over the last four weeks, aTyr Pharma lost 3,230.61 percent. Over the last 12 months, its price rose by 710.54 percent. Looking ahead, we forecast aTyr Pharma to be priced at 5.97 by the end of this quarter and at 5.57 in one year, according to Trading Economics global macro models projections and analysts expectations.
aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.